NewsRx

Search our medical news database

Russian Academy of Sciences

Immunization with mucin 1 and its coding DNA had anti-tumor effect

Published in Law and Health Weekly, January 14th, 2006

Double immunization of mice with mucin 1 and its coding DNA had an anti-tumor effect.

Researchers in Russia and the Netherlands conducted a study "to evaluate the antitumor effect of mouse immunization with human mucin 1 gene (muc1) DNA plasmids combined with simultaneous injections of human mucin I (MUC1) protein."

"MUC1 DNA was cloned in pBK-CMV to prepare DNA plasmids and in pET22b+ to produce proteins. Three strains of mice, immunized with DNA or DNA plus MUC1, were inoculated with tumor cells obtained from spontaneous tumors. IgG2a , production, MUC1-specific IFN-gamma-producing CD8+ T cells, tumor growth and mouse survival were...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook